Research ArticleCancer

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

See allHide authors and affiliations

Science Translational Medicine  23 Jan 2019:
Vol. 11, Issue 476, eaat9321
DOI: 10.1126/scitranslmed.aat9321
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article